COVID-19 vaccine mRNA and Spike induce cell signaling pathways favoring the growth of tumor cells

Authors: Federico, Maurizio

Source journal: Oncotarget (2026-11-18)

DOI: 10.18632/oncotarget.28927

Abstract

Copyright: © 2026 Federico. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Billions of doses of the mRNA-based COVID-19 vaccines have been dispensed worldwide. Vaccine mRNA molecules enter cells due to their complexing with synthetic lipids. Afterwards, the synthetic mRNA translates into a full-length, biologically active, and stabilized form of the SARS-CoV-2 Spike protein. Both mRNA and Spike molecules possess intrinsic signaling properties. Vaccine mRNA induces cell responses similar to those elicited by microbial RNA, including the release of downstream soluble factors like IFNα, IFNγ, and IL-6. Spike activates cell signaling pathways, such as those driven by NF-κB, ERK, and AKT, by binding to the angiotensin-converting enzyme (ACE)-2 cell receptor, cell membrane integrins, and other signaling molecules, both intracellularly and extracellularly. This research perspective offers a detailed analysis of the effects on cell signaling induced by both the vaccine mRNA and the Spike protein. A bulk of experimental data supports the idea that these effects, alone and in combination, can switch molecular mechanisms that both directly and indirectly contribute to the neoformation and growth of cancer cells. This possibility calls for additional investigations, considering that, in any case, favoring the growth of tumor cells does not necessarily imply the development of clinically evident tumors, which require additional, still largely unknown conditions.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.